Table 2. Correlation of cytosolic TMEM88 overexpression with clinicopathologicalfeatures in breast cancer.
Clinicopathological factors | All specimens | Triple-positive specimens | Triple-negative specimens | ||||||
---|---|---|---|---|---|---|---|---|---|
Positive | Negative | p | Positive | Negative | p | Positive | Negative | p | |
Age | |||||||||
<52 | 33 | 36 | 0.126 | 20 | 24 | 0.241 | 13 | 12 | 0.604 |
≥52 | 43 | 27 | 19 | 12 | 24 | 15 | |||
TNM classification | |||||||||
I + II | 49 | 51 | 0.038 | 34 | 27 | 0.239 | 15 | 24 | <0.001 |
III | 27 | 12 | 9 | 5 | 22 | 3 | |||
Lymph node metastasis | |||||||||
Positive | 36 | 44 | 0.01 | 15 | 12 | 0.81 | 25 | 7 | 0.002 |
Negative | 40 | 19 | 24 | 24 | 12 | 20 |